742.513585

[Ãëàâíàÿ/Ïîèñê] [Ïðîèçâîäèòåëè] [Ìîñêâà] [Ñ-Ïá] [Äðóãèå] [Îáùèé] [Çàÿâêè] [Âûáîðêà]

Öåíû íà ÝÂÀÌÅÍÎË ÌÀÇÜ ÍÀÇ. 15 Ã ÒÓÁÀ - ÝÕÈÍÀÖÅß ÏÓÐÏÓÐÍÀß ÒÐÀÂÀ Ô/Ï 2Ã ¹20

Ïðîäàâåö: ÍÀÄÅÆÄÀ ÔÀÐÌ (Õàáàðîâñê, óë. Ìåòàëëèñòîâ,4 òåë.: (4212) 57-48-87)

ÍàèìåíîâàíèåÏðîèçâîäèòåëüÖåíà $Öåíà ðóá
ÝÂÀÌÅÍÎË ÌÀÇÜ ÍÀÇ. 15 Ã ÒÓÁÀÌÎÑÊÎÂÑÊÀß ÔÀÐÌ Ô-ÊÀ ÇÀÎ26.01
ÝÂÈÑÅÍÒ ÄÐÎÆÆÈ ÏÈÂÍÛÅ Ñ ÌÀÃÍÈÅÌ ÒÀÁ 0,5 ¹90ÀËÊÎÉ161.62
ÝÂÈÑÅÍÒ ÄÐÎÆÆÈ ÏÈÂÍÛÅ Ñ ÖÈÍÊÎÌ È ÑÅËÅÍÎÌ ÒÀÁ 0,5 ¹90ÄÐÎÆÆÅÂÛÅ ÒÅÕÍÎËÎÃÈÈ ÎÎÎ161.66
ÝÂÈÑÅÍÒ ÌÀÑÊÀ ÄÐÎÆÆÈ Ñ ÑÅÐÎÉ Ä/ÏÐÎÁË.ÊÎÆÈ 75ÌËÒÂÈÍÑ-ÒÝÊ ÇÀÎ309.3
ÝÂÊÀËÈÏÒ ËÈÑÒ 75ÃÊÐÀÑÍÎÃÎÐÑÊËÅÊÑÐÅÄÑÒÂÀ33.44
ÝÂÊÀËÈÏÒ ËÈÑÒ 75ÃÊÐÀÑÍÎÃÎÐÑÊËÅÊÑÐÅÄÑÒÂÀ35.96
ÝÂÊÀËÈÏÒ ËÈÑÒ Ô/Ï 1,5Ã ¹20ÇÄÎÐÎÂÜÅ ÇÀÎ32.34
ÝÂÊÀËÈÏÒ-Ì ÏÀÑÒÈËÊÈ ¹24NATUR PRODUKT95.83
ÝÂÊÀËÈÏÒ-Ì ÒÀÁ Ä/ÐÀÑÑÀÑ ¹20NATUR PRODUKT81.29
ÝÂÊÀËÈÏÒ-Ì ÒÀÁ Ä/ÐÀÑÑÀÑ ¹20NATUR PRODUKT86.99
ÝÂÊÀÑÅÏÒ ÊÀÏË. ÍÀÇ. 10 ÌË ÔË/ÊÀÏÑ-ÏÅÒÅÐÁÓÐÃÑÊÀß ÔÔ42.79
ÝÂÊÀÑÅÏÒ ÊÀÏË. ÍÀÇ. 10 ÌË ÔË/ÊÀÏÑ-ÏÅÒÅÐÁÓÐÃÑÊÀß ÔÔ50.6
ÝÃÈËÎÊ ÒÀÁ 100ÌÃ ¹30EGIS131.41
ÝÃÈËÎÊ ÒÀÁ 100ÌÃ ¹30EGIS141.34
ÝÃÈËÎÊ ÒÀÁ 100ÌÃ ¹60EGIS195.39
ÝÃÈËÎÊ ÒÀÁ 25ÌÃ ¹60EGIS128.01
ÝÃÈËÎÊ ÒÀÁ 50ÌÃ ¹60EGIS152.63
ÝÃÈÒÐÎÌÁ ÒÀÁË. Ï/Î 75ÌÃ ¹28EGIS1016.29
ÝÃÈÒÐÎÌÁ ÒÀÁË. Ï/Î 75ÌÃ ¹28EGIS1089.39
ÝÃËÎÍÈË ÊÀÏÑ. 0,05 ¹30ÑÀÍÎÔÈ ÂÈÍÒÐÎÏ ÈÍÄÓÑÒÐÈß224.75
ÝÃËÎÍÈË ÒÀÁ. 200ÌÃ ¹12ÑÀÍÎÔÈ ÂÈÍÒÐÎÏ ÈÍÄÓÑÒÐÈß341.11
ÝÄÀÑ-127 ÊÀÏËÈ (ÏÐÈ ÌÀÑÒÎÏÀÒÈÈ) 25 ÌËÝÄÀÑ204.28
ÝÄÍÈÒ ÒÀÁ 10ÌÃ ¹20ÃÅÄÅÎÍ ÐÈÕÒÅÐ À.Î.77.9
ÝÄÍÈÒ ÒÀÁ 10ÌÃ ¹20ÃÅÄÅÎÍ ÐÈÕÒÅÐ À.Î.79.02
ÝÄÍÈÒ ÒÀÁ 10ÌÃ ¹20ÃÅÄÅÎÍ ÐÈÕÒÅÐ À.Î.79.05
ÝÄÍÈÒ ÒÀÁ 2,5ÌÃ ¹20ÃÅÄÅÎÍ ÐÈÕÒÅÐ À.Î.44.96
ÝÄÍÈÒ ÒÀÁ 2,5ÌÃ ¹20ÃÅÄÅÎÍ ÐÈÕÒÅÐ À.Î.51.28
ÝÄÍÈÒ ÒÀÁ 2,5ÌÃ ¹20ÃÅÄÅÎÍ ÐÈÕÒÅÐ À.Î.53.06
ÝÄÍÈÒ ÒÀÁ 20ÌÃ ¹20ÃÅÄÅÎÍ ÐÈÕÒÅÐ À.Î.123.33
ÝÄÍÈÒ ÒÀÁ 5ÌÃ ¹20ÃÅÄÅÎÍ ÐÈÕÒÅÐ À.Î.62.44
ÝÄÍÈÒ ÒÀÁ 5ÌÃ ¹20ÃÅÄÅÎÍ ÐÈÕÒÅÐ À.Î.62.44
ÝÊÂÀÒÎÐ ÒÀÁ. 5ÌÃ+10ÌÃ ¹10ÃÅÄÅÎÍ ÐÈÕÒÅÐ À.Î.207.56
ÝÊÂÀÒÎÐ ÒÀÁ. 5ÌÃ+10ÌÃ ¹30ÃÅÄÅÎÍ ÐÈÕÒÅÐ À.Î.549.1
ÝÊÇÈÔÈÍ ÒÀÁ 250ÌÃ ¹16DR. REDDYS LAB.675.02
ÝÊÇÎÄÅÐÈË ÊÐÅÌ 1%-15Ã.MERCK KGAA342.7
ÝÊÇÎÄÅÐÈË ÐÀÑÒÂÎÐ 1% 10ÌËGLOBOPHARM424.18
ÝÊÇÎÄÅÐÈË ÐÀÑÒÂÎÐ 1% 10ÌËSANDOZ GMBH424.7
ÝÊÎËËÀ "ÇÈÌÍÈÉ ÓÕÎÄ" ÁÀËÜÇÀÌ Ä/ÃÓÁ ÇÀÙÈÒÍÛÉ 4,6ÃÁÈÎÊÎÍ ÌÅÄ ÍÏÎ43.93
ÝÊÎËËÀ "ÇÈÌÍÈÉ ÓÕÎÄ" ÊÐÅÌ Ä/ÍÎÃ ÑÎÃÐÅÂÀÞÙ. 90ÌËÁÈÎÊÎÍ ÌÅÄ ÍÏÎ68.09
ÝÊÎËËÀ "ÇÈÌÍÈÉ ÓÕÎÄ" ÊÐÅÌ Ä/ÍÎÃ ÑÎÃÐÅÂÀÞÙ. 90ÌËÁÈÎÊÎÍ ÌÅÄ ÍÏÎ73.22
ÝÊÎËËÀ "ÇÈÌÍÈÉ ÓÕÎÄ" ÊÐÅÌ Ä/ÐÓÊ ÇÀÙÈÒ. ÏÈÒÀÒ. 90ÌËÁÈÎÊÎÍ ÌÅÄ ÍÏÎ65.83
ÝÊÎËËÀ "ÇÈÌÍÈÉ ÓÕÎÄ" ÊÐÅÌ Ä/ÐÓÊ ÇÀÙÈÒ. ÏÈÒÀÒ. 90ÌËÁÈÎÊÎÍ ÌÅÄ ÍÏÎ73.22
ÝÊÎËËÀ "ÇÈÌÍÈÉ ÓÕÎÄ" ÊÐÅÌ-ÌÀÑÊÀ Ä/ËÈÖÀ ÏÈÒÀÒ. 60ÌËÁÈÎÊÎÍ ÌÅÄ ÍÏÎ98.01
ÝÊÎËËÀ "ÇÈÌÍÈÉ ÓÕÎÄ" ÊÐÅÌ-ÌÀÑÊÀ Ä/ËÈÖÀ ÏÈÒÀÒ. 60ÌËÁÈÎÊÎÍ ÌÅÄ ÍÏÎ98.11
ÝÊÎËËÀ "ÇÈÌÍÈÉ ÓÕÎÄ" ÍÀÁÎÐ Ä/ËÈÖÀ (ÊÐÅÌ ÇÀÙÈÒ.+ÊÐÅÌ-ÌÀÑÊÀ)ÁÈÎÊÎÍ ÌÅÄ ÍÏÎ162.54
ÝÊÎËËÀ "ÇÈÌÍÈÉ ÓÕÎÄ" ÍÀÁÎÐ Ä/ËÈÖÀ È ÐÓÊÁÈÎÊÎÍ ÌÅÄ ÍÏÎ144.97
ÝÊÎËËÀ "ÇÈÌÍÈÉ ÓÕÎÄ" ÍÀÁÎÐ Ä/ËÈÖÀ È ÐÓÊÁÈÎÊÎÍ ÌÅÄ ÍÏÎ144.97
ÝÊÎËËÀ ÃÅËÜ Ä/ÊÎÆÈ ÂÎÊÐÓÃ ÃËÀÇ 25ÌËÁÈÎÊÎÍ ÌÅÄ ÍÏÎ46.81
ÝÊÎËËÀ ÃÅËÜ-ÄÅÎÄÎÐÀÍÒ Ä/ÍÎÃ ÎÑÂÅÆ. 90ÌËÁÈÎÊÎÍ ÌÅÄ ÍÏÎ47.2
ÝÊÎËËÀ ÊÐÅÌ Ä/ÍÎà ÏÈÒÀÒ/ÑÌßÃ×ÀÞÙÈÉ 90ÌËÁÈÎÊÎÍ ÌÅÄ ÍÏÎ42.42
ÝÊÎËËÀ ÊÐÅÌ Ä/ÍÎà ÏÈÒÀÒ/ÑÌßÃ×ÀÞÙÈÉ 90ÌËÁÈÎÊÎÍ ÌÅÄ ÍÏÎ42.47
ÝÊÎËËÀ ÊÐÅÌ Ä/ÐÓÊ ÄÍÅÂÍÎÉ 90ÌËÁÈÎÊÎÍ ÌÅÄ ÍÏÎ42.47
ÝÊÎËËÀ ÊÐÅÌ Ä/ÐÓÊ ÍÎ×ÍÎÉ 90ÌËÁÈÎÊÎÍ ÌÅÄ ÍÏÎ42.47
ÝÊÎËËÀ ÊÐÅÌ ÏÈÒÀÒ/ÂÎÑÑÒ/ÍÎ×ÍÎÉ 75ÌËÁÈÎÊÎÍ ÌÅÄ ÍÏÎ46.81
ÝÊÎËËÀ ÊÐÅÌ ÓÂËÀÆÍßÞÙÈÉ ÄÍÅÂ. 75ÌËÁÈÎÊÎÍ ÌÅÄ ÍÏÎ46.86
ÝÊÎËËÀ ÊÐÅÌ-ÀÊÒÈÂ ÏÐ/ÌÎÐÙÈÍ ÐÅÃÅÍÅÐÈÐÓÞÙÈÉ 75ÌËÁÈÎÊÎÍ ÌÅÄ ÍÏÎ51.2
ÝÊÎËËÀ ÊÐÅÌ-ÀÊÒÈÂ ÏÐ/ÌÎÐÙÈÍ ÐÅÃÅÍÅÐÈÐÓÞÙÈÉ 75ÌËÁÈÎÊÎÍ ÌÅÄ ÍÏÎ51.25
ÝÊÎËËÀ ÊÐÅÌ-ÃÅËÜ ÓÂËÀÆÍßÞÙÈÉ, ÌÀÒÈÐÓÞÙÈÉ 75ÌËÁÈÎÊÎÍ ÌÅÄ ÍÏÎ46.86
ÝÊÎËËÀ ÊÐÅÌ-ËÈÔÒÈÍÃ Ä/ÊÎÆÈ ÂÎÊÐÓÃ ÃËÀÇ 25ÌËÁÈÎÊÎÍ ÌÅÄ ÍÏÎ51.2
ÝÊÎËËÀ ÍÀÁÎÐ "ÎÁÍÎÂËÅÍÈÅ È ÒÎÍÓÑ" (ÊÐÅÌ ÎÒ ÌÎÐÙÈÍ,ÃÅËÜ Ä/ÃËÀÇ)ÁÈÎÊÎÍ ÌÅÄ ÍÏÎ87.13
ÝÊÎËËÀ ÍÀÁÎÐ "ÏÈÒÀÍÈÅ È ÂÎÑÑÒÀÍ." (ÊÐÅÌ ÍÎ×Í.,ÃÅËÜ Ä/ÃËÀÇ)ÁÈÎÊÎÍ ÌÅÄ ÍÏÎ78.83
ÝÊÎËËÀ ÍÀÁÎÐ "ÓÂËÀÆÍÅÍÈÅ È ÑÂÅÆÅÑÒÜ" (ÊÐÅÌ ÄÍ.,ÃÅËÜ Ä/ÃËÀÇ,ÊÐÅÌ Ä/ÐÓÊ)ÁÈÎÊÎÍ ÌÅÄ ÍÏÎ114.95
ÝÊÎËËÀ ÏÅÍÊÀ Ä/ÓÌÛÂÀÍÈß Ä/ÑÓÕ/×ÓÂÑÒ. ÊÎÆÈ 150ÌËÁÈÎÊÎÍ ÌÅÄ ÍÏÎ51.2
ÝÊÎËËÀ ÏÅÍÊÀ Ä/ÓÌÛÂÀÍÈß Ä/ÑÓÕ/×ÓÂÑÒ. ÊÎÆÈ 150ÌËÁÈÎÊÎÍ ÌÅÄ ÍÏÎ51.25
ÝÊÎËËÀ ÑÊÐÀÁ Ä/ËÈÖÀ 75ÌËÁÈÎÊÎÍ ÌÅÄ ÍÏÎ46.86
ÝÊÎÔÅÌÈÍ ÃÅËÜ ÆÅÍÑÊÈÉ ÈÍÒÈÌÍ. 50 ÌËÀÍÒÎÍ ÕÞÁÍÅÐ ÃÌÁÕ382.35
ÝÊÎÔÅÌÈÍ ÃÅËÜ ÆÅÍÑÊÈÉ ÈÍÒÈÌÍ. 50 ÌËÀÍÒÎÍ ÕÞÁÍÅÐ ÃÌÁÕ382.35
ÝÊÑËÞÒÎÍ ÒÀÁ. 0,5Ã ¹28ORGANON1153.33
ÝÊÑËÞÒÎÍ ÒÀÁ. 0,5Ã ¹28ORGANON1156.27
ÝËÅÂÈÒ ÏÐÎÍÀÒÀËÜ ÒÀÁ. Ï/Î ¹ 30ROTTENDORF PHARMA400.24
ÝËÅÓÒÅÐÎÊÎÊÊ-ÏËÞÑ ÄÐÀÆÅ 0,18 ¹100ÁÈÎÊÎÐ61.65
ÝËÅÓÒÅÐÎÊÎÊÊ-ÏËÞÑ ÄÐÀÆÅ 0,18 ¹50ÁÈÎÊÎÐ36.54
ÝËÅÓÒÅÐÎÊÎÊÊÀ ÝÊ-Ò ÆÈÄÊÈÉ ÔË. 50ÌË ÈÍÄ/ÓÏÄÀËÜÕÈÌÔÀÐÌ ÎÀÎ23.9
ÝËÅÓÒÅÐÎÊÎÊÊÀ ÝÊ-Ò ÆÈÄÊÈÉ ÔË. 50ÌË ÈÍÄ/ÓÏÄÀËÜÕÈÌÔÀÐÌ ÎÀÎ24.69
ÝËÅÓÒÅÐÎÊÎÊÊÀ ÝÊ-Ò ÆÈÄÊÈÉ ÔË. 50ÌË ÈÍÄ/ÓÏÄÀËÜÕÈÌÔÀÐÌ ÎÀÎ24.76
ÝËÅÓÒÅÐÎÊÎÊÊÀ ÝÊ-Ò ÆÈÄÊÈÉ ÔË. 50ÌË ÈÍÄ/ÓÏÄÀËÜÕÈÌÔÀÐÌ ÎÀÎ28.12
ÝËÅÓÒÅÐÎÊÎÊÊÀ ÝÊ-Ò ÆÈÄÊÈÉ ÔË. 50ÌË ÈÍÄ/ÓÏÄÀËÜÕÈÌÔÀÐÌ ÎÀÎ28.46
ÝËÅÓÒÅÐÎÊÎÊÊÀ ÝÊ-Ò ÆÈÄÊÈÉ ÔË. 50ÌË ÈÍÄ/ÓÏÄÀËÜÕÈÌÔÀÐÌ ÎÀÎ28.46
ÝËÅÓÒÅÐÎÊÎÊÊÀ ÝÊ-Ò ÒÀÁ. Ï/Î 100ÌÃ ¹30ÂÈÔÈÒÅÕ71.23
ÝËÅÔËÎÊÑ Ð-Ð Ä/ÈÍÔ. 5 ÌÃ/ÌË 100 ÌË ÔË. ¹1RANBAXY/ALCON452.19
ÝËÅÔËÎÊÑ Ð-Ð Ä/ÈÍÔ. 5 ÌÃ/ÌË 100 ÌË ÔË. ¹1RANBAXY/ALCON459.32
ÝËÇÅÏÀÌ Ð-Ð Ä/ÈÍ.0,1% ÀÌÏ. 1ÌË ¹10ÝËËÀÐÀ ÌÖ ÎÎÎ118.72
ÝËÈÊÑÈÐ "ÀËÒÀÉÑÊÈÉ" 100ÌËËÞÌÈ77.08
ÝËÈÊÑÈÐ "ÄÅÌÈÄÎÂÑÊÈÉ" 100ÌËËÞÌÈ77.08
ÝËÈÊÑÈÐ "ÊÅÄÐÎÂÈÒ" 250ÌËÌÅËÈÃÅÍ160.97
ÝËÎÊÎÌ ÊÐÅÌ 0,1% 15ÃSCHERING-PLOUGH398.42
ÝËÎÊÎÌ ÊÐÅÌ 0,1% 15ÃSCHERING396.46
ÝËÎÊÎÌ ËÎÑÜÎÍ 0,1 %-20 ÌËSCHERING-PLOUGH197.22
ÝËÎÊÎÌ ÌÀÇÜ 0,1% 15ÃSCHERING-PLOUGH400.96
ÝËÎÊÎÌ-Ñ ÌÀÇÜ 15ÃSCHERING-PLOUGH542.51
ÝËÎÊÎÌ-Ñ ÌÀÇÜ 15ÃSCHERING508.92
ÝËÎÊÎÌ-Ñ ÌÀÇÜ 15ÃSCHERING524.55
ÝËÜÊÀÐ Ð/Ð Ä/ÂÍÓÒÐ. ÏÐÈÌ. 30% 100 ÌËÏÈÊ-ÔÀÐÌÀ ÎÎÎ551.57
ÝËÜÊÀÐ Ð/Ð Ä/ÂÍÓÒÐ. ÏÐÈÌ. 30% 50 ÌËÏÈÊ-ÔÀÐÌÀ ÎÎÎ360.73
ÝËÜÊÀÐ Ð/Ð Ä/ÂÍÓÒÐ. ÏÐÈÌ. 30% 50 ÌËÏÈÊ-ÔÀÐÌÀ ÎÎÎ361.62
ÝËÜÔÀÑÅÏÒ ÔÈÒÎ ÑÈÐÎÏ 100ÌËÝËÜÔÀ ÇÀÎ/ÝËÜÔÀ ËÀÁÎÐÀÒÎÐÈÇ81.43
ÝËÜÔÀÑÅÏÒ ÔÈÒÎ-ËÎÐ ÏÀÑÒÈËÊÈ ¹ 20 ÀÍÀÍÀÑÝËÜÔÀ ÇÀÎ/ÝËÜÔÀ ËÀÁÎÐÀÒÎÐÈÇ48.86
ÝËÜÔÀÑÅÏÒ ÔÈÒÎ-ËÎÐ ÏÀÑÒÈËÊÈ ¹ 20 ÀÏÅËÜÑÈÍÝËÜÔÀ ÇÀÎ/ÝËÜÔÀ ËÀÁÎÐÀÒÎÐÈÇ48.86
ÝËÜÔÀÑÅÏÒ ÔÈÒÎ-ËÎÐ ÏÀÑÒÈËÊÈ ¹ 20 ËÈÌÎÍ/ÌÅÄÝËÜÔÀ ÇÀÎ/ÝËÜÔÀ ËÀÁÎÐÀÒÎÐÈÇ48.86
ÝËÜÔÀÑÅÏÒ ÔÈÒÎ-ËÎÐ ÏÀÑÒÈËÊÈ ¹ 20 ËÈÌÎÍÝËÜÔÀ ÇÀÎ/ÝËÜÔÀ ËÀÁÎÐÀÒÎÐÈÇ48.86
ÝËÜÔÀÑÅÏÒ ÔÈÒÎ-ËÎÐ ÏÀÑÒÈËÊÈ ¹ 20 ÌÀËÈÍÀÝËÜÔÀ ÇÀÎ/ÝËÜÔÀ ËÀÁÎÐÀÒÎÐÈÇ48.86
ÝËÜÔÀÑÅÏÒ ÔÈÒÎ-ËÎÐ ÏÀÑÒÈËÊÈ ¹ 20 ÌßÒÀÝËÜÔÀ ÇÀÎ/ÝËÜÔÀ ËÀÁÎÐÀÒÎÐÈÇ48.86
ÝÌËÀ ÊÐÅÌ 5% 5 Ã ¹ 5ÀÑÒÐÀÇÅÍÅÊÀ ÀÁ1354.45
ÝÌÎÊÑÈ-ÎÏÒÈÊ ÃË. ÊÀÏ 1% 5,0 ÔË.(ÝÌÎÊÑÈÏÈÍ)ÑÈÍÒÅÇ ( ÊÓÐÃÀÍ)ÎÀÎÐÎÑÑÈß21.58
ÝÌÎÊÑÈ-ÎÏÒÈÊ ÃË. ÊÀÏ 1% 5,0 ÔË.(ÝÌÎÊÑÈÏÈÍ)ÑÈÍÒÅÇ ( ÊÓÐÃÀÍ)ÎÀÎÐÎÑÑÈß21.97
ÝÌÎÊÑÈÏÈÍ Ð-Ð Ä/ÈÍ 1% 1ÌË ¹10 ÀÌÏÌÎÑÊÎÂÑÊÈÉ ÝÍÄÎÊÐÈÍÍÛÉ ÇÀÂÎÄ120.6
ÝÍÀËÀÏÐÈË ÒÀÁ 10ÌÃ ¹20HEXAL AG/SALUTAS PHARMA76.59
ÝÍÀËÀÏÐÈË ÒÀÁ 10ÌÃ ¹20ÁÈÎÑÈÍÒÅÇ ÎÀÎ6.44
ÝÍÀËÀÏÐÈË ÒÀÁ 10ÌÃ ¹20ÕÅÌÎÔÀÐÌ À.Ä./ÕÅÌÎÔÀÐÌ ÐÎÑÑÈß69.08
ÝÍÀËÀÏÐÈË ÒÀÁ 2.5ÌÃ ¹20AGIO4.62
ÝÍÀËÀÏÐÈË ÒÀÁ 20ÌÃ ¹20ÊÀÍÎÍÔÀÐÌÀ ÏÐÎÄÀÊØÍ ÇÀÎ10.25
ÝÍÀËÀÏÐÈË ÒÀÁ 20ÌÃ ¹20ÊÀÍÎÍÔÀÐÌÀ ÏÐÎÄÀÊØÍ ÇÀÎ10.3
ÝÍÀËÀÏÐÈË ÒÀÁ 20ÌÃ ¹20ÊÀÍÎÍÔÀÐÌÀ ÏÐÎÄÀÊØÍ ÇÀÎ10.3
ÝÍÀËÀÏÐÈË ÒÀÁ 5ÌÃ ¹20AGIO4.62
ÝÍÀËÀÏÐÈË ÒÀÁ 5ÌÃ ¹20AGIO4.9
ÝÍÀËÀÏÐÈË ÒÀÁ 5ÌÃ ¹20HEXAL AG/SALUTAS PHARMA59.65
ÝÍÀËÀÏÐÈË ÒÀÁ 5ÌÃ ¹20ÊÀÍÎÍÔÀÐÌÀ ÏÐÎÄÀÊØÍ ÇÀÎ7.43
ÝÍÀËÀÏÐÈË ÒÀÁ 5ÌÃ ¹20ÕÅÌÎÔÀÐÌ À.Ä./ÕÅÌÎÔÀÐÌ ÐÎÑÑÈß48.82
ÝÍÀËÀÏÐÈË ÒÀÁ 5ÌÃ ¹20ÕÅÌÎÔÀÐÌ À.Ä./ÕÅÌÎÔÀÐÌ ÐÎÑÑÈß49.77
ÝÍÀËÀÏÐÈË-ÔÏÎ ÒÀÁ 10 ÌÃ ¹20ÎÁÎËÅÍÑÊÎÅ ÔÀÐÌ. ÏÐÅÄÏÐÈßÒÈÅ ÇÀÎ31.71
ÝÍÀËÀÏÐÈË-ÔÏÎ ÒÀÁ 10 ÌÃ ¹20ÎÁÎËÅÍÑÊÎÅ ÔÀÐÌ. ÏÐÅÄÏÐÈßÒÈÅ ÇÀÎ31.71
ÝÍÀËÀÏÐÈË-ÔÏÎ ÒÀÁ 5 ÌÃ ¹20ÎÁÎËÅÍÑÊÎÅ ÔÀÐÌ. ÏÐÅÄÏÐÈßÒÈÅ ÇÀÎ31.55
ÝÍÀËÀÏÐÈË-ÔÏÎ ÒÀÁ 5 ÌÃ ¹20ÎÁÎËÅÍÑÊÎÅ ÔÀÐÌ. ÏÐÅÄÏÐÈßÒÈÅ ÇÀÎ31.55
ÝÍÀËÀÏÐÈË-ÔÏÎ ÒÀÁ. 20 ÌÃ ¹20ÎÁÎËÅÍÑÊÎÅ ÔÀÐÌ. ÏÐÅÄÏÐÈßÒÈÅ ÇÀÎ42.87
ÝÍÀËÀÏÐÈË-ÔÏÎ ÒÀÁ. 20 ÌÃ ¹20ÎÁÎËÅÍÑÊÎÅ ÔÀÐÌ. ÏÐÅÄÏÐÈßÒÈÅ ÇÀÎ48.15
ÝÍÀËÀÏÐÈË-ÔÏÎ ÒÀÁ. 20 ÌÃ ¹20ÎÁÎËÅÍÑÊÎÅ ÔÀÐÌ. ÏÐÅÄÏÐÈßÒÈÅ ÇÀÎ48.31
ÝÍÀËÀÏÐÈË-ÔÏÎ ÒÀÁ. 20 ÌÃ ¹20ÎÁÎËÅÍÑÊÎÅ ÔÀÐÌ. ÏÐÅÄÏÐÈßÒÈÅ ÇÀÎ48.31
ÝÍÀÌ ÒÀÁ 10ÌÃ ¹20DR. REDDYS LAB.67.3
ÝÍÀÌ ÒÀÁ 2,5ÌÃ ¹20DR. REDDYS LAB.25.08
ÝÍÀÌ ÒÀÁ 20ÌÃ ¹20DR. REDDYS LAB.113.53
ÝÍÀÌ ÒÀÁ 5ÌÃ ¹20DR. REDDYS LAB.41.75
ÝÍÀÏ ÒÀÁ 10ÌÃ ¹20ÊÐÊÀ-ÐÓÑ ÎÎÎ86.3
ÝÍÀÏ ÒÀÁ 2,5ÌÃ ¹20ÊÐÊÀ/ÂÅÊÒÎÐ-ÌÅÄÈÊÀ64.64
ÝÍÀÏ ÒÀÁ 20ÌÃ ¹20ÊÐÊÀ-ÐÓÑ ÎÎÎ129.38
ÝÍÀÏ ÒÀÁ 5ÌÃ ¹20ÊÐÊÀ-ÐÓÑ ÎÎÎ71.08
ÝÍÀÏ ÒÀÁ 5ÌÃ ¹20ÊÐÊÀ-ÐÓÑ ÎÎÎ71.08
ÝÍÀÏ ÒÀÁ 5ÌÃ ¹20ÊÐÊÀ-ÐÓÑ ÎÎÎ72.06
ÝÍÀÏ-H ÒÀÁ 10ÌÃ/25ÌÃ ¹20KRKA131.25
ÝÍÄÎÊÐÈÍÎË ÊÀÏÑ. ¹30ÝÂÀËÀÐ135.13
ÝÍÄÎÊÐÈÍÎË ÊÐÅÌ-ÃÅËÜ 50ÌËÝÂÀËÀÐ122.64
ÝÍÅÐÈÎÍ ÒÀÁ. Ï/Î 200ÌÃ ¹20ËÀÁÎÐÀÒÎÐÈÈ ÑÅÐÂÜÅ463.14
ÝÍÇÀÏÐÎÑÒ-Ô Ð-Ð Ä/ÈÍ. 5ÌÃ/ÌË ÀÌÏ. 1ÌË ¹5CHINOIN1803.05
ÝÍÇÈÑÒÀË ÒÀÁ. Ï/Î ¹20TORRENT89.89
ÝÍÒÅÐÎË ÊÀÏÑ 250ÌÃ ¹10ÁÈÎÊÎÄÅÊÑ140
ÝÍÒÅÐÎÔÓÐÈË ÊÀÏÑ. 100ÌÃ ¹30BOSNALIJEK197.39
ÝÍÒÅÐÎÔÓÐÈË ÊÀÏÑ. 200ÌÃ ¹16BOSNALIJEK197.82
ÝÍÒÅÐÎÔÓÐÈË ÑÓÑÏ. Ä/ÂÍ. ÏÐÈÌ. 200ÌÃ/5ÌË ÔË. 90ÌËBOSNALIJEK278.27
ÝÍÖÅÔÀÁÎË ÒÀÁ Ï/Î 100ÌÃ ¹50MERCK KGAA582.48
ÝÍÖÅÔÀÁÎË ÒÀÁ Ï/Î 100ÌÃ ¹50MERCK KGAA582.48
ÝÏÈÃÅÍ ÈÍÒÈÌ ÃÅËÜ 250ÌËCHEMINOVA INTERNACIONAL461.58
ÝÏÈÃÅÍ ÈÍÒÈÌ ÑÏÐÅÉ 0,1% 60ÌËCHEMINOVA INTERNACIONAL1079.14
ÝÐÃÎÔÅÐÎÍ ÒÀÁ. Ä/ÐÀÑÑÀÑÛÂ. ¹20ÌÀÒÅÐÈÀ ÌÅÄÈÊÀ229.46
ÝÐÅÑÏÀË ÑÈÐÎÏ 2 ÌÃ/ÌË 150 ÌËSERVIER289.18
ÝÐÅÑÏÀË ÒÀÁ. Ï/Î 80ÌÃ ¹30SERVIER349.11
ÝÐÅÑÏÀË ÒÀÁ. Ï/Î 80ÌÃ ¹30SERVIER351.55
ÝÐÅÑÏÀË ÒÀÁ. Ï/Î 80ÌÃ ¹30SERVIER351.55
ÝÐÅÑÏÀË ÒÀÁ. Ï/Î 80ÌÃ ¹30SERVIER389.76
ÝÐÅÑÏÀË ÒÀÁ. Ï/Î 80ÌÃ ¹30SERVIER391.41
ÝÐÈÄÅÊÎ 11 (5Ë)1451.67
ÝÐÈÍÈÒ ÒÀÁ 0,01 ¹50ÔÀÐÌÀÏÎË-ÂÎËÃÀ ÎÎÎ47.45
ÝÐÈÒÐÎÌÈÖÈÍ ÌÀÇÜ 10000 ÅÄ/Ã 15ÃÁÈÎÑÈÍÒÅÇ ÎÀÎ16.57
ÝÐÈÒÐÎÌÈÖÈÍ ÌÀÇÜ 10000 ÅÄ/Ã 15ÃÁÈÎÑÈÍÒÅÇ ÎÀÎ16.73
ÝÐÈÒÐÎÌÈÖÈÍ ÌÀÇÜ 10000 ÅÄ/Ã 15ÃÁÈÎÑÈÍÒÅÇ ÎÀÎ16.95
ÝÐÈÒÐÎÌÈÖÈÍ ÌÀÇÜ ÃË. 10000 ÅÄ/Ã 10ÃÑÈÍÒÅÇ ( ÊÓÐÃÀÍ)ÎÀÎÐÎÑÑÈß22.06
ÝÐÈÒÐÎÌÈÖÈÍ ÌÀÇÜ ÃË. 10000 ÅÄ/Ã 10ÃÑÈÍÒÅÇ ( ÊÓÐÃÀÍ)ÎÀÎÐÎÑÑÈß22.4
ÝÐÈÒÐÎÌÈÖÈÍ ÌÀÇÜ ÃË. 10000 ÅÄ/Ã 10ÃÑÈÍÒÅÇ ( ÊÓÐÃÀÍ)ÎÀÎÐÎÑÑÈß22.86
ÝÐÈÒÐÎÌÈÖÈÍ ÒÀÁ Ï/Î 0,25 ¹10ÑÒÈÌÅÄÑÎÐÁ21.7
ÝÐÈÒÐÎÌÈÖÈÍ ÒÀÁ Ï/Î 0,25 ¹10ÑÒÈÌÅÄÑÎÐÁ21.7
ÝÐÈÒÐÎÌÈÖÈÍ ÒÀÁ Ï/Î 0,25 ¹20ÑÒÈÌÅÄÑÎÐÁ80.59
ÝÐÈÒÐÎÌÈÖÈÍ ÒÀÁ Ï/Î 0,25 ¹20ÑÒÈÌÅÄÑÎÐÁ81.75
ÝÐÈÒÐÎÌÈÖÈÍÀ ËÈÎÔ. Ä/Ð-ÐÀ Â/Â 100ÌÃ ÔË.ÑÈÍÒÅÇ ( ÊÓÐÃÀÍ)ÎÀÎÐÎÑÑÈß10.06
ÝÐÈÒÐÎÌÈÖÈÍÀ ËÈÎÔ. Ä/Ð-ÐÀ Â/Â 100ÌÃ ÔË.ÑÈÍÒÅÇ ( ÊÓÐÃÀÍ)ÎÀÎÐÎÑÑÈß10.93
ÝÐÈÓÑ ÑÈÐÎÏ 0,5ÌÃ/ÌË 120 ÌË ÔËSCHERING-PLOUGH683.12
ÝÐÈÓÑ ÑÈÐÎÏ 0,5ÌÃ/ÌË 60ÌË ÔËSCHERING-PLOUGH511.61
ÝÐÈÓÑ ÒÀÁ. Ï/Î 5ÌÃ ¹10SCHERING-PLOUGH517.05
ÝÐÈÓÑ ÒÀÁ. Ï/Î 5ÌÃ ¹7SCHERING-PLOUGH394.08
ÝÐÈÓÑ ÒÀÁ. Ï/Î 5ÌÃ ¹7ØÅÐÈÍÃ-ÏËÀÓ/ÁÅÍ ÂÅÍÜÞ ËÀÁÎÐÀÒÎÐÈÑ ÈÍÊ380.49
ÝÐÑÅÔÓÐÈË ÊÀÏÑ 200ÌÃ ¹28SANOFI-CHINOIN418.08
ÝÐÑÅÔÓÐÈË ÊÀÏÑ 200ÌÃ ¹28ÑÀÍÎÔÈ ÂÈÍÒÐÎÏ ÈÍÄÓÑÒÐÈß407.7
ÝÐÑÅÔÓÐÈË ÊÀÏÑ 200ÌÃ ¹28ÑÀÍÎÔÈ-ÂÈÍÒÐÎÏ ÈÍÄÀÑÒÐÈ397.76
ÝÑÊÀÏÅË ÒÀÁ 1,5ÌÃ ¹1ÃÅÄÅÎÍ ÐÈÕÒÅÐ À.Î.341.42
ÝÑÊÀÏÅË ÒÀÁ 1,5ÌÃ ¹1ÃÅÄÅÎÍ ÐÈÕÒÅÐ À.Î.342.78
ÝÑÊÎÐÄÈ ÊÎÐ ÒÀÁË. 5ÌÃ ¹30ÝÌÊÞÐ ÔÀÐÌÀÑÜÞÒÈÊÀËÇ481.99
ÝÑÊÓÇÀÍ ÊÀÏËÈ 20ÌËWERNIGERODE PHARMA107.66
ÝÑÊÓÇÀÍ ÊÀÏËÈ 20ÌËWERNIGERODE PHARMA107.78
ÝÑÊÓÇÀÍ ÊÀÏËÈ 20ÌËWERNIGERODE PHARMA107.78
ÝÑËÈÄÈÍ ÊÀÏÑ. ¹30ÌÀÊÈÇ-ÔÀÐÌÀ ÇÀÎ353.43
ÝÑÏÀÍÄÅÐ ÊÈÑÒÅÂÎÉ ÄÅÒÑÊÈÉÒÎÐÃ ËÀÉÍÑ26.08
ÝÑÏÀÍÄÅÐ ÊÈÑÒÅÂÎÉ ÄÅÒÑÊÈÉÒÎÐÃ ËÀÉÍÑ39.56
ÝÑÏÅÐÀËÜ ÒÀÁ 0,5 ¹20SANOFI-CHINOIN630.35
ÝÑÏÅÐÀËÜ ÒÀÁ 0,5 ¹20SOFARIMEX594.96
ÝÑÏÅÐÀËÜ ÒÀÁ 0,5 ¹20SOFARIMEX598.83
ÝÑÏÅÐÀËÜ ÒÀÁ 0,5 ¹20ÑÀÍÎÔÈ ÂÈÍÒÐÎÏ ÈÍÄÓÑÒÐÈß608.71
ÝÑÏÎË 10% 30Ã ÌÀÇÜÍÈÆÔÀÐÌ ÎÀÎ131.53
ÝÑÏÎË 10% 30Ã ÌÀÇÜÍÈÆÔÀÐÌ ÎÀÎ133.52
ÝÑÏÓÌÈÇÀÍ L ÝÌÓËÜÑÈß 40 ÌÃ/ÌË 30 ÌËBERLIN CHEMI/MENARINI285.86
ÝÑÏÓÌÈÇÀÍ ÊÀÏÑ. 40ÌÃ ¹25BERLIN-CHEMIE184.92
ÝÑÏÓÌÈÇÀÍ ÊÀÏÑ. 40ÌÃ ¹50BERLIN CHEMI/MENARINI335.5
ÝÑÑÅÍÖÈÀËÅ Í Ð-Ð Â/Â ÀÌÏ 50ÌÃ/ÌË 5ÌË ¹5ÑÀÍÎÔÈ-ÀÂÅÍÒÈÑ Ô./ÑÀÍÎÔÈ ÂÈÍÒÐÎÏ È.690.05
ÝÑÑÅÍÖÈÀËÅ Í Ð-Ð Â/Â ÀÌÏ 50ÌÃ/ÌË 5ÌË ¹5ÑÀÍÎÔÈ-ÀÂÅÍÒÈÑ Ô./ÑÀÍÎÔÈ ÂÈÍÒÐÎÏ È.702.64
ÝÑÑÅÍÖÈÀËÅ ÔÎÐÒÅ-Í ÊÀÏÑ ¹30A.NATTERMANN&CIE GMBH458.83
ÝÑÑÅÍÖÈÀËÅ ÔÎÐÒÅ-Í ÊÀÏÑ ¹30A.NATTERMANN&CIE GMBH483.06
ÝÑÑÅÍÖÈÀËÅ ÔÎÐÒÅ-Í ÊÀÏÑ ¹30A.NATTERMANN&CIE GMBH484.17
ÝÑÑÅÍÖÈÀËÅ ÔÎÐÒÅ-Í ÊÀÏÑ ¹30AVENTIS/NATTERMANN486.64
ÝÑÑËÈÂÅÐ ÔÎÐÒÅ ÊÀÏÑ. ¹30ÍÀÁÐÎÑ/ÍÈÆÔÀÐÌ205.14
ÝÑÑËÈÂÅÐ ÔÎÐÒÅ ÊÀÏÑ. ¹50NABROS/ÍÈÆÔÀÐÌ263.85
ÝÑÑËÈÂÅÐ ÔÎÐÒÅ ÊÀÏÑ. ¹50NABROS/ÍÈÆÔÀÐÌ268.5
ÝÑÑËÈÂÅÐ ÔÎÐÒÅ ÊÀÏÑ. ¹50ÍÀÁÐÎÑ/ÍÈÆÔÀÐÌ266.33
ÝÒÀÌÁÓÒÎË ÒÀÁ 0,4 ¹100ÀÊÐÈÕÈÍ ÕÔÊ ÎÀÎ178.58
ÝÒÀÌÁÓÒÎË ÒÀÁ 0,4 ¹100ÀÊÐÈÕÈÍ ÕÔÊ ÎÀÎ184.1
ÝÒÀÌÁÓÒÎË ÒÀÁ 0,4 ¹100ÀÊÐÈÕÈÍ ÕÔÊ ÎÀÎ192.47
ÝÒÀÌÇÈËÀÒ ÒÀÁ 0,25 ¹50ËÓÃÀÍÑÊÈÉ ÕÔÇ31.16
ÝÒÀÌÇÈËÀÒ ÒÀÁ 0,25 ¹50ËÓÃÀÍÑÊÈÉ ÕÔÇ31.17
ÝÒÀÌÇÈËÀÒ ÒÀÁ 0,25 ¹50ËÓÃÀÍÑÊÈÉ ÕÔÇ31.5
ÝÓÒÈÐÎÊÑ ÒÀÁ 100 ÌÊÃ ¹100MERCK KGAA144.82
ÝÓÒÈÐÎÊÑ ÒÀÁ 100 ÌÊÃ ¹100MERCK KGAA144.85
ÝÓÒÈÐÎÊÑ ÒÀÁ 125 ÌÊÃ ¹100MERCK KGAA185.19
ÝÓÒÈÐÎÊÑ ÒÀÁ 125 ÌÊÃ ¹100MERCK KGAA187.2
ÝÓÒÈÐÎÊÑ ÒÀÁ 150 ÌÊÃ ¹100MERCK KGAA186.03
ÝÓÒÈÐÎÊÑ ÒÀÁ 25 ÌÊÃ ¹100MERCK KGAA104.94
ÝÓÒÈÐÎÊÑ ÒÀÁ 50 ÌÊÃ ¹100MERCK KGAA130.44
ÝÓÔÈËËÈÍ ÀÌÏ 2,4%-10,0 ¹10ÄÀËÜÕÈÌÔÀÐÌ ÎÀÎ36.29
ÝÓÔÈËËÈÍ ÀÌÏ 2,4%-10,0 ¹10ÄÀËÜÕÈÌÔÀÐÌ ÎÀÎ36.29
ÝÓÔÈËËÈÍ ÀÌÏ 2,4%-10,0 ¹10ÄÀËÜÕÈÌÔÀÐÌ ÎÀÎ36.29
ÝÓÔÈËËÈÍ ÀÌÏ 2,4%-10,0 ¹10ÄÀËÜÕÈÌÔÀÐÌ ÎÀÎ36.29
ÝÓÔÈËËÈÍ ÀÌÏ 2,4%-5,0 ¹10ÀÐÌÀÂÈÐÑÊÀß ÁÈÎËÎÃ. Ô-ÊÀ24.95
ÝÓÔÈËËÈÍ ÀÌÏ 2,4%-5,0 ¹10ÀÐÌÀÂÈÐÑÊÀß ÁÈÎËÎÃ. Ô-ÊÀ25.57
ÝÓÔÈËËÈÍ ÀÌÏ 24%-1,0 ¹10ÄÀËÜÕÈÌÔÀÐÌ ÎÀÎ54.65
ÝÓÔÈËËÈÍ ÒÀÁ 0,15 ¹30ÁÎÐÈÑÎÂÑÊÈÉ ÇÀÂÎÄ ÌÅÄÏÐÅÏÀÐÀÒÎÂ ÎÀÎ7.48
ÝÓÔÈËËÈÍ ÒÀÁ 0,15 ¹30ÁÎÐÈÑÎÂÑÊÈÉ ÇÀÂÎÄ ÌÅÄÏÐÅÏÀÐÀÒÎÂ ÎÀÎ7.5
ÝÓÔÈËËÈÍ ÒÀÁ 0,15 ¹30ÈÐÁÈÒÑÊÈÉ ÕÔÇ7.62
ÝÓÔÈËËÈÍ ÒÀÁ 0,15 ¹30ÈÐÁÈÒÑÊÈÉ ÕÔÇ7.62
ÝÓÔÈËËÈÍ ÒÀÁ 0,15 ¹30ÈÐÁÈÒÑÊÈÉ ÕÔÇ7.62
ÝÔÎÊÑ ËÎÍÃ ÐÅÒÀÐÄ ÊÀÏÑ 50ÌÃ ¹30SCHWARZ PHARMA393.95
ÝÔÎÊÑ ËÎÍÃ ÐÅÒÀÐÄ ÊÀÏÑ 50ÌÃ ¹30SCHWARZ PHARMA397.94
ÝÔÎÊÑ ËÎÍÃ ÐÅÒÀÐÄ ÒÀÁ 50ÌÃ ¹30SCHWARZ PHARMA340.96
ÝÔÔÅÐÀËÃÀÍ ÑÈÐ. Ä/ÄÅÒ 3% 90ÌËBRISTOL-MYERS SGUIBB90.92
ÝÔÔÅÐÀËÃÀÍ ÑÈÐ. Ä/ÄÅÒ 3% 90ÌËBRISTOL-MYERS SGUIBB95.69
ÝÔÔÅÐÀËÃÀÍ ÒÀÁ. ØÈÏÓ×. 500ÌÃ ¹16BRISTOL-MYERS SGUIBB101.52
ÝÔÔÅÐÀËÃÀÍ ÒÀÁ. ØÈÏÓ×. 500ÌÃ ¹16BRISTOL-MYERS SGUIBB102.62
ÝÔÔÅÐÀËÃÀÍ ÒÀÁ. ØÈÏÓ×. 500ÌÃ ¹16UPSA99.48
ÝÔÔÅÐÀËÃÀÍ ÒÀÁ. ØÈÏÓ×. Ñ ÂÈÒ. Ñ ¹10BRISTOL-MYERS SGUIBB72.81
ÝÕÈÍÀÖÅÈ ÍÀÑÒÎÉÊÀ ÄÎÊÒÎÐ ÒÀÉÑÑ 50ÌËDR. THEISS NATURWAREN160.5
ÝÕÈÍÀÖÅÈ ÏÓÐÏÓÐÍÎÉ Í-ÊÀ 50ÌËÂÀÒÕÝÌ-ÔÀÐÌÀÖÈß23.98
ÝÕÈÍÀÖÅÈ ÏÓÐÏÓÐÍÎÉ Í-ÊÀ 50ÌËÂÀÒÕÝÌ-ÔÀÐÌÀÖÈß27.57
ÝÕÈÍÀÖÅÈ ÏÓÐÏÓÐÍÎÉ Í-ÊÀ 50ÌËÂÀÒÕÝÌ-ÔÀÐÌÀÖÈß37.78
ÝÕÈÍÀÖÅß ÏÓÐÏÓÐÍÀß ÒÐÀÂÀ 50ÃËÅÊ Ñ+33.82
ÝÕÈÍÀÖÅß ÏÓÐÏÓÐÍÀß ÒÐÀÂÀ 50ÃËÅÊ Ñ+33.9
ÝÕÈÍÀÖÅß ÏÓÐÏÓÐÍÀß ÒÐÀÂÀ Ô/Ï 2Ã ¹20ËÅÊ Ñ+32.59





2001-2011 http://www.med.sgg.ru - öåíû íà ëåêàðñòâà, ìåäòåõíèêó, âñå äëÿ ñòîìàòîëîãèè, õèðóðãè÷åñêèé è äðóãîé ìåäèöèíñêèé èíñòðóìåíò è òåõíèêà, ôàðìàöåâòè÷åñêèå ïðåïàðàòû è ñóáñòàíöèè îò ïðîèçâîäèòåëåé è îïòîâûõ ïðîäàâöîâ â Ìîñêâå, Ñàíêò-Ïåòåðáóðãå è äðóãèõ ðåãèîíàõ.



Rambler's Top100 Rambler's Top100 Ðåéòèíã@Mail.ru